Nearly 10,000 heart attack patients to test ancient pill for better recovery
Disease control
Not yet recruiting
This large study will test whether adding Shexiang Baoxin Pill (Muskardia) to standard treatment helps people who have had a heart attack. About 9,588 participants will receive either standard care alone or standard care plus the pill for 12 months. The goal is to see if the pill…
Phase: PHASE4 • Sponsor: Shanghai Hutchison Pharmaceuticals Limited • Aim: Disease control
Last updated Jun 26, 2026 13:58 UTC